ATE551061T1 - Lna-nukleosid-phosphoramidate - Google Patents

Lna-nukleosid-phosphoramidate

Info

Publication number
ATE551061T1
ATE551061T1 AT06805565T AT06805565T ATE551061T1 AT E551061 T1 ATE551061 T1 AT E551061T1 AT 06805565 T AT06805565 T AT 06805565T AT 06805565 T AT06805565 T AT 06805565T AT E551061 T1 ATE551061 T1 AT E551061T1
Authority
AT
Austria
Prior art keywords
lna nucleoside
nucleoside phosphoramidate
phosphoramidate
lna
formula
Prior art date
Application number
AT06805565T
Other languages
English (en)
Inventor
Christoph Rosenbohm
Jacob Jensen
Troels Koch
Original Assignee
Santaris Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santaris Pharma As filed Critical Santaris Pharma As
Application granted granted Critical
Publication of ATE551061T1 publication Critical patent/ATE551061T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT06805565T 2006-11-13 2006-11-13 Lna-nukleosid-phosphoramidate ATE551061T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/DK2006/000627 WO2007054100A2 (en) 2006-11-13 2006-11-13 Lna nucleoside phosphoramidates

Publications (1)

Publication Number Publication Date
ATE551061T1 true ATE551061T1 (de) 2012-04-15

Family

ID=37853036

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06805565T ATE551061T1 (de) 2006-11-13 2006-11-13 Lna-nukleosid-phosphoramidate

Country Status (4)

Country Link
EP (1) EP2099461B1 (de)
AT (1) ATE551061T1 (de)
DK (1) DK2099461T3 (de)
WO (1) WO2007054100A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014066239A1 (en) * 2012-10-22 2014-05-01 Idenix Pharmaceuticals, Inc. 2',4'-bridged nucleosides for hcv infection
GB201410693D0 (en) 2014-06-16 2014-07-30 Univ Southampton Splicing modulation
AU2015327836B2 (en) 2014-10-03 2021-07-01 Cold Spring Harbor Laboratory Targeted augmentation of nuclear gene output
KR20220105174A (ko) 2015-10-09 2022-07-26 유니버시티 오브 사우스앰톤 유전자 발현의 조절 및 탈조절된 단백질 발현의 스크리닝
US11096956B2 (en) 2015-12-14 2021-08-24 Stoke Therapeutics, Inc. Antisense oligomers and uses thereof
EP3933041B1 (de) 2015-12-14 2024-01-31 Cold Spring Harbor Laboratory Antisense-oligomere zur behandlung von autosomaldominierender geistiger behinderung
CN111278991B (zh) 2017-08-25 2022-04-01 斯托克制药公司 用于治疗病况和疾病的反义寡聚体
CA3173647A1 (en) 2020-05-11 2021-11-18 Isabel AZNAREZ Opa1 antisense oligomers for treatment of conditions and diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002351077A1 (en) * 2001-11-05 2003-05-19 Exiqon A/S Oligonucleotides modified with novel alpha-l-rna analogues
GB0317009D0 (en) * 2003-07-21 2003-08-27 Univ Cardiff Chemical compounds

Also Published As

Publication number Publication date
DK2099461T3 (da) 2012-07-02
EP2099461A2 (de) 2009-09-16
WO2007054100A2 (en) 2007-05-18
EP2099461B1 (de) 2012-03-28
WO2007054100A3 (en) 2007-10-04

Similar Documents

Publication Publication Date Title
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
ATE551061T1 (de) Lna-nukleosid-phosphoramidate
EA200801428A1 (ru) Производные пиридиазинона для лечения опухолей
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
CY1111793T1 (el) Μυκητοκτονες συνθεσεις
DK1853602T3 (da) Kemiske forbindelser
DK1853588T3 (da) Kemiske forbindelser
UA107791C2 (en) Pesticidal compositions
MY153915A (en) Organic compounds
DOP2009000159A (es) Inhibidores de la poli(adp-ribosa) polimerasa
EA201170832A1 (ru) Пуриновые соединения
UY29612A1 (es) Compuestos quimicos ii
SG171617A1 (en) Therapeutic compounds
PA8667201A1 (es) Nuevos compuestos farmaceuticos
NO20083923L (no) Pyrazolkinoloner er potente parp-inhibitorer
ME01459B (me) Postupak za doziranje medikamenata
GT200800251A (es) Nitrilos espirociclicos como inhibidores de proteasa
TNSN08191A1 (en) Kinase inhibitors
UY31688A1 (es) Plaguicidas
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
EA200801145A1 (ru) Спироциклические производные хиназолина в качестве ингибиторов pde7
EA200970372A1 (ru) Ингибитор развития болезни альцгеймера, содержащий гетероциклическое соединение
UY30451A1 (es) 18-metil-19-nor-androst-4-en-17,17-espiroéteres (18-metil-19-nor-20-espirox-4-en-3-onas),ase como preparaciones farmacéuticas que lo contienen.
SG158091A1 (en) Imidazoazepinone compounds
PA8792401A1 (es) Fenilendiaminas